These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20575692)

  • 1. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
    Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
    J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
    Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
    Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
    Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
    Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
    Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and
    Salimi S; Shahrakipour M; Hajizadeh A; Mokhtari M; Mousavi M; Teimoori B; Yaghmaei M
    Biomed Rep; 2017 Feb; 6(2):237-241. PubMed ID: 28357079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
    Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
    Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
    Wang Y; Li Z; Liu N; Zhang G
    Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.